466 related articles for article (PubMed ID: 7478608)
1. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo.
Muthuswamy SK; Muller WJ
Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608
[TBL] [Abstract][Full Text] [Related]
2. Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor.
Muthuswamy SK; Muller WJ
Oncogene; 1995 Jul; 11(2):271-9. PubMed ID: 7542762
[TBL] [Abstract][Full Text] [Related]
3. Protein tyrosine phosphatase epsilon activates Yes and Fyn in Neu-induced mammary tumor cells.
Granot-Attas S; Elson A
Exp Cell Res; 2004 Mar; 294(1):236-43. PubMed ID: 14980517
[TBL] [Abstract][Full Text] [Related]
4. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src.
Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS
Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
Amundadottir LT; Leder P
Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
[TBL] [Abstract][Full Text] [Related]
6. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
7. Neu-mediated phosphorylation of protein tyrosine phosphatase epsilon is critical for activation of Src in mammary tumor cells.
Berman-Golan D; Elson A
Oncogene; 2007 Oct; 26(49):7028-37. PubMed ID: 17486066
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase epsilon and Neu-induced mammary tumorigenesis.
Berman-Golan D; Granot-Attas S; Elson A
Cancer Metastasis Rev; 2008 Jun; 27(2):193-203. PubMed ID: 18231724
[TBL] [Abstract][Full Text] [Related]
9. Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity.
Muthuswamy SK; Siegel PM; Dankort DL; Webster MA; Muller WJ
Mol Cell Biol; 1994 Jan; 14(1):735-43. PubMed ID: 7903421
[TBL] [Abstract][Full Text] [Related]
10. Role of SRC kinases in Neu-induced tumorigenesis: challenging the paradigm using Csk homologous kinase transgenic mice.
Kaminski R; Zagozdzon R; Fu Y; Mroz P; Fu W; Seng S; Avraham S; Avraham HK
Cancer Res; 2006 Jun; 66(11):5757-62. PubMed ID: 16740714
[TBL] [Abstract][Full Text] [Related]
11. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice.
Guy CT; Muthuswamy SK; Cardiff RD; Soriano P; Muller WJ
Genes Dev; 1994 Jan; 8(1):23-32. PubMed ID: 7507074
[TBL] [Abstract][Full Text] [Related]
12. Differential activation of pp60(c-src) and pp62(c-yes) in human colorectal carcinoma liver metastases.
Han NM; Curley SA; Gallick GE
Clin Cancer Res; 1996 Aug; 2(8):1397-404. PubMed ID: 9816313
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
Ram TG; Ethier SP
Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
[TBL] [Abstract][Full Text] [Related]
14. Activation of src-related tyrosine kinases by IL-3.
Anderson SM; Jorgensen B
J Immunol; 1995 Aug; 155(4):1660-70. PubMed ID: 7636226
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma.
Loganzo F; Dosik JS; Zhao Y; Vidal MJ; Nanus DM; Sudol M; Albino AP
Oncogene; 1993 Oct; 8(10):2637-44. PubMed ID: 7690926
[TBL] [Abstract][Full Text] [Related]
16. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
Susa M; Rohner D; Bichsel S
Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
[TBL] [Abstract][Full Text] [Related]
17. The SH4-Unique-SH3-SH2 domains dictate specificity in signaling that differentiate c-Yes from c-Src.
Summy JM; Qian Y; Jiang BH; Guappone-Koay A; Gatesman A; Shi X; Flynn DC
J Cell Sci; 2003 Jun; 116(Pt 12):2585-98. PubMed ID: 12734402
[TBL] [Abstract][Full Text] [Related]
18. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer.
Dankort D; Maslikowski B; Warner N; Kanno N; Kim H; Wang Z; Moran MF; Oshima RG; Cardiff RD; Muller WJ
Mol Cell Biol; 2001 Mar; 21(5):1540-51. PubMed ID: 11238891
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation at the membrane-microfilament interface: a p185neu-associated signal transduction particle containing Src, Abl and phosphorylated p58, a membrane- and microfilament-associated retroviral gag-like protein.
Juang SH; Carvajal ME; Whitney M; Liu Y; Carraway CA
Oncogene; 1996 Mar; 12(5):1033-42. PubMed ID: 8649794
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
Zhai YF; Beittenmiller H; Wang B; Gould MN; Oakley C; Esselman WJ; Welsch CW
Cancer Res; 1993 May; 53(10 Suppl):2272-8. PubMed ID: 8097963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
